Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Asthma and Eosinophilic Cationic Protein as an Indicator of Disease Control (CROSBI ID 297209)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Čičak, Biserka ; Verona, Eva ; Bukovac, Željka ; Mihatov, Iva Asthma and Eosinophilic Cationic Protein as an Indicator of Disease Control // Acta clinica Croatica, 44 (2005), 3; 251-257

Podaci o odgovornosti

Čičak, Biserka ; Verona, Eva ; Bukovac, Željka ; Mihatov, Iva

engleski

Asthma and Eosinophilic Cationic Protein as an Indicator of Disease Control

Asthma is the most common chronic disease in children and adolescents. It is necessary to develop objective methods for assessment of disease activity, treatment efficacy, and prevention of attacks. Measurements of eosinophilic cationic protein (ECP) should serve as an objective indicator of allergic inflammation activity. This follow-up study included 100 children treated with inhaled corticosteroid (fluticasone propionate) or sodium cromoglycate over a 12-month period. The values of (ECP) and forced expiratory volume in the first second (FEV1) were measured at the beginning of the study and then once a month for a year, to evaluate treatment efficacy. The fastest drop in ECP values and the highest increase in FEV1 were found in children with newly diagnosed asthma, who were treated with inhalation corticosteroid. This result supports the importance of early introduction of anti- inflammatory therapy in childhood asthma.

asthma-physiopathology, asthma-blood, eosinophils-immunology, asthma-therapy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

44 (3)

2005.

251-257

objavljeno

0353-9466

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost